109 related articles for article (PubMed ID: 2501023)
1. Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.
Grossie VB; Ota DM; Ajani JA; Chang TH; Patenia D; Nishioka K
Cancer Res; 1989 Aug; 49(15):4159-62. PubMed ID: 2501023
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithine.
Grossie VB; Ota DM; Ajani JA; Nishioka K
Invest New Drugs; 1991 Nov; 9(4):321-6. PubMed ID: 1804805
[TBL] [Abstract][Full Text] [Related]
3. Reduced tissue ornithine increases the cytotoxicity of difluoromethylornithine.
Grossie VB; Nishioka K
Anticancer Res; 1996; 16(6B):3731-5. PubMed ID: 9042249
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
Grossie VB; Ota DM; Ajani JA; Nishioka K
Cancer Res; 1987 Apr; 47(7):1836-40. PubMed ID: 3102050
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
6. Effect of ornithine in parenteral nutrition regimens on difluoromethylornithine-induced platelet suppression and changes in tumor polyamine content.
Grossie VB; Nishioka K
Cancer Invest; 1998; 16(3):160-5. PubMed ID: 9541629
[TBL] [Abstract][Full Text] [Related]
7. Alpha-difluoromethylornithine-induced inhibition of growth of autochthonous experimental colonic tumors produced by azoxymethane in male F344 rats.
Zhang SZ; Luk GD; Hamilton SR
Cancer Res; 1988 Nov; 48(22):6498-503. PubMed ID: 3141045
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of oral carcinogenesis by DL-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats.
Tanaka T; Kojima T; Hara A; Sawada H; Mori H
Cancer Res; 1993 Feb; 53(4):772-6. PubMed ID: 8428357
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
11. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
12. Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels.
Ajani JA; Ota DM; Grossie VB; Levin B; Nishioka K
Cancer Res; 1989 Oct; 49(20):5761-5. PubMed ID: 2507135
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis.
Uchida K; Seidenfeld J; Rademaker A; Oyasu R
Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487
[TBL] [Abstract][Full Text] [Related]
14. Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: effects on esophageal cell proliferation and apoptosis.
Fong LY; Pegg AE; Magee PN
Cancer Res; 1998 Dec; 58(23):5380-8. PubMed ID: 9850069
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice].
Umemoto S
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897
[TBL] [Abstract][Full Text] [Related]
16. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
[TBL] [Abstract][Full Text] [Related]
17. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Persons D; Slepetis RJ; Taylor D; Bartolome J
Teratology; 1984 Oct; 30(2):211-24. PubMed ID: 6208628
[TBL] [Abstract][Full Text] [Related]
18. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effects of dietary D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis.
Kojima T; Tanaka T; Kawamori T; Hara A; Mori H
Cancer Res; 1993 Sep; 53(17):3903-7. PubMed ID: 8358715
[TBL] [Abstract][Full Text] [Related]
20. Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.
Harris WB; Grossie VB; Ota DM; Nishioka K; Ajani JA; Chang T; Patenia D
J Surg Res; 1985 Jun; 38(6):592-8. PubMed ID: 3925242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]